|
⚲
|
| Keyboard |
| Newhall Charles W III
✚
|
|
|---|---|
| CIK # | 0001005544 |
| EDGAR Form | CIK | 2011 - 2026 |
|---|---|---|
| 3 | [0001005544] | |
| 4 | [0001005544] | |
| 5 | [0001005544] |
| Insider Transaction (Form 3/4/5) | Date | Action | Shares | Price | Value ($) |
|---|---|---|---|---|---|
|
Supernus Pharmaceuticals Inc SUPN
Common Stock
|
2026-02-24 | Grant | 4,475 | $0.00 | |
|
Supernus Pharmaceuticals Inc SUPN
Restricted Stock Unit · derivative
|
2026-02-24 | Disposed to issuer | 4,475 | $0.00 | |
|
Supernus Pharmaceuticals Inc SUPN
Director Stock Option (Right to Buy) · derivative
|
2026-02-18 | Grant | 4,977 | $0.00 | |
|
Supernus Pharmaceuticals Inc SUPN
Restricted Stock Unit · derivative
|
2026-02-18 | Grant | 2,989 | $0.00 | |
|
Supernus Pharmaceuticals Inc SUPN
Director Stock Option (Right to Buy) · derivative
|
2025-11-21 | Option exercise | 15,000 | $0.00 | |
|
Supernus Pharmaceuticals Inc SUPN
Common Stock
|
2025-11-21 | Option exercise | 15,000 | $12.98 | 194,700 |
|
Supernus Pharmaceuticals Inc SUPN
Common Stock
|
2025-10-09 | Sell | 1,200 | $51.55 | 61,860 |
|
Supernus Pharmaceuticals Inc SUPN
Common Stock
|
2025-10-09 | Sell | 23,800 | $50.73 | 1,207,374 |
|
Supernus Pharmaceuticals Inc SUPN
Common Stock
|
2025-02-22 | Grant | 5,369 | $0.00 | |
|
Supernus Pharmaceuticals Inc SUPN
Restricted Stock Units · derivative
|
2025-02-22 | Disposed to issuer | 5,369 | $0.00 | |
|
Supernus Pharmaceuticals Inc SUPN
Restricted Stock Unit · derivative
|
2025-02-19 | Grant | 4,475 | $0.00 | |
|
Supernus Pharmaceuticals Inc SUPN
Director Stock Option (Right to Buy) · derivative
|
2025-02-19 | Grant | 7,296 | $0.00 | |
|
Supernus Pharmaceuticals Inc SUPN
Common Stock
|
2024-11-11 | Option exercise | 20,000 | $9.13 | 182,600 |
|
Supernus Pharmaceuticals Inc SUPN
Common Stock
|
2024-11-11 | Sell | 10,700 | $36.24 | 387,768 |
|
Supernus Pharmaceuticals Inc SUPN
Director Stock Option (Right to Buy) · derivative
|
2024-11-11 | Option exercise | 20,000 | $0.00 | |
|
Supernus Pharmaceuticals Inc SUPN
Common Stock
|
2024-02-23 | Grant | 3,886 | $0.00 | |
|
Supernus Pharmaceuticals Inc SUPN
Restricted Stock Unit · derivative
|
2024-02-23 | Disposed to issuer | 3,886 | $0.00 | |
|
Supernus Pharmaceuticals Inc SUPN
Restricted Stock Units · derivative
|
2024-02-22 | Grant | 5,369 | $0.00 | |
|
Supernus Pharmaceuticals Inc SUPN
Director Stock Option (Right to Buy) · derivative
|
2024-02-22 | Grant | 8,252 | $0.00 | |
|
Supernus Pharmaceuticals Inc SUPN
Common Stock
|
2023-11-16 | Option exercise | 7,457 | $9.24 | 68,903 |
| showing 20 of 143 most recent transactions | |||||